BMP4 and neoplasm: Rather, the approach of using hAMSCs as therapeutic delivery vehicles for anti-cancer agents such as BMP4 (Li et al.30) may increase the ability of hAMSCs to inhibit brain tumor cell proliferation and malignancy while taking advantage of their innate tumor tropic abilities.